Technology ❯ Artificial Intelligence ❯ Machine Learning ❯ Generative Models
Researchers have created a multi-neoantigen vaccine blueprint alongside de novo protein binders that achieved precise T cell–mediated melanoma cell killing in vitro, now advancing into animal safety studies.
